XML 32 R36.htm IDEA: XBRL DOCUMENT v2.4.0.8
LICENSE AGREEMENTS (Details Textual) (USD $)
 3 Months Ended 6 Months Ended 12 Months Ended 1 Months Ended 6 Months Ended 1 Months Ended 1 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Jun. 30, 2014
Jun. 30, 2013
Dec. 30, 2012
Dec. 31, 2013
Jun. 23, 2014
Ligand [Member]
Jun. 30, 2014
Ligand [Member]
Jun. 23, 2014
Ligand [Member]
Maximum [Member]
Jun. 23, 2014
Ligand [Member]
Minimum [Member]
Jun. 23, 2014
Opus Point Partners, Llc [Member]
Jun. 23, 2014
Opus Point Partners, Llc [Member]
Maximum [Member]
Jun. 30, 2014
Research and Development Expense [Member]
Jun. 30, 2014
Research and Development Expense [Member]
License Agreement [Line Items]                            
License revenue $ 38,095 $ 38,095 $ 76,190 $ 76,190                    
Deferred Revenue 1,752,381   1,752,381     1,829,000                
Additional Amount Receivable On Achievement Of Pre Specified Milestones     5,000,000,000                      
Income taxes         330,000                  
Business Acquisition Purchase Agreement Period Description     license revenue on a straight-line basis over the life of the agreement, which is through the expiration of the last licensed patent right or 15 years after the first commercial sale of a product in such country, unless the agreement is earlier terminated                      
Proceeds from Fees Received         2,000,000                  
Stock Issued During Period, Shares, Issued for Services               125,000            
Non Cash Stock Expense 1,211,250 0 1,211,250 0                 1,211,250 1,211,250
Maximum Potential Payments Payable             207,000,000              
Royalty payment Effective Percentage                 9.50% 6.00% 1.00%      
Maximum sales for royalty expense                 1,000,000,000     1,000,000,000    
Accounts and Other Receivables, Net, Current $ 152,000   $ 152,000